PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) Blues

Nick Beije, Wassim Abida, Emmanuel S. Antonarakis, Elena Castro, Ronald de Wit, Karim Fizazi, Silke Gillessen, Maha Hussain, Joaquin Mateo, Michael J. Morris, David Olmos, Oliver Sartor, Adam Sharp, Christopher J. Sweeney, Johann S. de Bono

Research output: Contribution to journalEditorialpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)253-256
Number of pages4
JournalEuropean Urology
Issue number3
StatePublished - Sep 2023


  • Androgen receptor signalling inhibitor
  • Castration-resistant prostate cancer
  • Metastatic prostate cancer
  • PARP inhibitor

PubMed: MeSH publication types

  • Editorial

Cite this